News
SNY
42.64
-0.20%
-0.09
Sanofi price target raised to EUR 100 from EUR 95 at HSBC
TipRanks · 1d ago
Sanofi, Regeneron Could Extend Dupixent Patent -- Market Talk
Dow Jones · 2d ago
Astra, Roche win new Outperform ratings as RBC initiates EU pharma coverage
Seeking Alpha · 2d ago
MacroGenics: Inexpensive ADC/TCE Biotech With Multiple Catalysts Ahead
Seeking Alpha · 2d ago
*Sanofi Started at Sector Perform by RBC
Dow Jones · 2d ago
FDA names acting heads of drug and vaccine units to permanent roles
Seeking Alpha · 2d ago
RBC Capital Initiates a Hold Rating on Sanofi (SNYNF)
TipRanks · 3d ago
Sanofi initiated with a Sector Perform at RBC Capital
TipRanks · 3d ago
Sanofi and Keke Palmer team up to urge parents to help protect babies from serious RSV with BEYFORTUS®
PR Newswire · 3d ago
Weekly Report: what happened at SNY last week (0831-0904)?
Weekly Report · 4d ago
Dianthus: Hold, Based On Competitor C1s' CIDP Setback And Continued Claseprubart Advancement
Seeking Alpha · 5d ago
Bank of America Securities Remains a Hold on Sanofi (SNYNF)
TipRanks · 6d ago
Does Moderna's mRNA Flu Shot Face a New Challenge From GSK?
NASDAQ · 09/03 16:24
Owkin Licenses K Pro AI Scientist And Multimodal Data To Boehringer Ingelheim
NASDAQ · 09/02 14:58
Deutsche Bank Reaffirms Their Buy Rating on Sanofi (SNYNF)
TipRanks · 09/02 11:05
Novartis: Today's Positive Remibrutinib Data Key To Unlocking Growth Plans
Seeking Alpha · 09/01 19:46
Eli Lilly to Buy Immunology Biotech Merida Biosciences in $2.9B Deal
NASDAQ · 09/01 17:10
The Multiple Sclerosis Drug Race Just Got Hotter After Novartis’ Phase 3 Win
Benzinga · 09/01 17:07
Novartis Stock (NVS) Pops as Multiple Sclerosis Drug Shows Positive Results in Late-Stage Trials
TipRanks · 09/01 14:17
Why Novartis Stock Is Heading for Its Best Day Since 2023 After 3 Patient Deaths
Barron‘s · 09/01 11:34
More
Webull provides a variety of real-time SNY stock news. You can receive the latest news about Sanofi FR through multiple platforms. This information may help you make smarter investment decisions.
About SNY
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.